药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Aminorex
Vilanterol
The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Entrectinib.
Aminorex
Olodaterol
The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Entrectinib.
Aminorex
Butriptyline
The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Entrectinib.
Aminorex
Eperisone
The risk or severity of QTc prolongation can be increased when Eperisone is combined with Entrectinib.
Aminorex
Fendiline
The risk or severity of QTc prolongation can be increased when Fendiline is combined with Entrectinib.
Aminorex
Flumequine
The risk or severity of QTc prolongation can be increased when Flumequine is combined with Entrectinib.
Aminorex
Indenolol
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Entrectinib.
Aminorex
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Entrectinib.
Aminorex
Bedaquiline
The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Entrectinib.
Aminorex
Eribulin
The risk or severity of QTc prolongation can be increased when Eribulin is combined with Entrectinib.
Aminorex
Lurasidone
The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Entrectinib.
Aminorex
Bupranolol
The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Entrectinib.
Aminorex
Antazoline
The risk or severity of QTc prolongation can be increased when Antazoline is combined with Entrectinib.
Aminorex
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Entrectinib.
Aminorex
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Entrectinib.
Aminorex
Triptorelin
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Entrectinib.
Aminorex
Histrelin
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Entrectinib.
Aminorex
Buserelin
The risk or severity of QTc prolongation can be increased when Buserelin is combined with Entrectinib.
Aminorex
Degarelix
The risk or severity of QTc prolongation can be increased when Degarelix is combined with Entrectinib.
Aminorex
Nemonoxacin
The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Entrectinib.